Results 1 to 10 of about 161,308 (319)
Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects [PDF]
Frontiers in Microbiology, 2018 Carbapenem-resistant Enterobacteriaceae (CRE), a major resistance concern emerging during the last decade because of significantly compromising the efficacy of carbapenem agents, has currently become an important focus of infection control.
Shio-Shin Jean +8 more
doaj +7 more sources
Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections [PDF]
Emerging Infectious Diseases, 2014 We evaluated the number of deaths attributable to carbapenem-resistant Enterobacteriaceae by using studies from around the world published before April 9, 2012.
Matthew E. Falagas +3 more
doaj +5 more sources
Paediatric Enterobacteriaceae infections in hospitalised children in Durban, KwaZulu-Natal
Southern African Journal of Infectious Diseases, 2021 Background: Community-acquired Gram-negative Enterobacteriaceae infections in malnourished and HIV-infected hospitalised children are not well documented and are of concern because of increasing antibiotic resistance and limited available treatment ...
Harshna Krishinchand +3 more
doaj +2 more sources
Carbapenem and colistin resistance in children with Enterobacteriaceae infections [PDF]
The Turkish Journal of Pediatrics, 2020 Background. Carbapenem-resistant Enterobacteriaceae (CRE) are an emerging global public health threat. As a reserve agent, colistin has been the drug of choice for the treatment of infections caused by CRE.
Zeliha Haytoğlu +5 more
doaj +4 more sources
Enterobacteriaceae infections in Saudi Arabia: a regression analysis [PDF]
Electronic Physician, 2019 Background: Carbapenem-resistant Enterobacteriaceae (CRE) are multidrug-resistant microorganisms. Infections caused by these microorganisms have limited treatment options, frequently leading to high mortality rates.
Reham Kaki
doaj +2 more sources
Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Children. [PDF]
J Pediatric Infect Dis Soc, 2020 AbstractInfections due to carbapenem-resistant Enterobacteriaceae (CRE) are increasingly prevalent in children and are associated with poor clinical outcomes. Optimal treatment strategies for CRE infections continue to evolve. A lack of pediatric-specific comparative effectiveness data, uncertain pediatric dosing regimens for several agents, and a ...
Chiotos K, Hayes M, Gerber JS, Tamma PD.
europepmc +5 more sources
Enterobacteriaceae infection – diagnosis, antibiotic resistance and prevention
Postępy Higieny i Medycyny Doświadczalnej, 2011 Intestinal infections caused by rod-shaped bacteria of the Enterobacteriaceae genus are one of the major health hazards in countries where sanitation standards are low. Strains of Shigella, Salmonella, Escherichia and Yersinia are responsible for diarrhea, severe bacillary dysentery, typhoid, other intestinal diseases, as well as genitourinary tract ...
Anna Jarząb +3 more
openalex +4 more sources
Therapeutic options for carbapenem-resistant Enterobacteriaceae infections. [PDF]
Virulence, 2017 In recent years, carbapenem resistance among Enterobacteriaceae has dramatically increased and represents an important threat to global health. The optimal therapeutic management of carbapenem-resistant Enterobacteriaceae (CRE) infections has not been established, because to date, no clinical trials have been performed with this objective.
Trecarichi EM, Tumbarello M.
europepmc +4 more sources
Carbapenem-Resistant Enterobacteriaceae Infections in Children. [PDF]
Curr Infect Dis Rep, 2016 Carbapenem-resistant Enterobacteriaceae (CRE) are an emerging global public health threat. Infections due to CRE are associated with significant morbidity and mortality. Few therapeutic options are available for treatment of these infections, and optimal antibiotic treatment regimens are unclear.
Chiotos K, Han JH, Tamma PD.
europepmc +5 more sources
Studies on the Enterobacteriaceae isolated from Urinary Infections
Juntendo Medical Journal, 1957 Shyoku FUJINO
openalex +4 more sources